Filing Details
- Accession Number:
- 0001225208-24-002453
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-20 17:05:20
- Reporting Period:
- 2024-02-15
- Accepted Time:
- 2024-02-20 17:05:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 21665 | Colgate Palmolive Co | CL | Perfumes, Cosmetics & Other Toilet Preparations (2844) | 131815595 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1464265 | R. Noel Wallace | C/O Colgate-Palmolive Company 300 Park Avenue New York NY 10022 | Chairman, President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-02-15 | 56,616 | $0.00 | 331,115 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2024-02-16 | 29,772 | $84.06 | 301,343 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-02-20 | 55,486 | $68.16 | 356,829 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-02-20 | 14,462 | $84.41 | 342,367 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-02-20 | 55,486 | $84.17 | 286,881 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-02-20 | 55,486 | $0.00 | 55,486 | $68.16 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2024-09-13 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 51,697 | Indirect | By Issuer's 401(k) Plan Trustee |
| Common Stock | 52,000 | Indirect | By Spouse Trust |
| Common Stock | 335 | Indirect | By Trust |
Footnotes
- Represents vesting of a previously-granted performance-based restricted stock unit ("PBRSU") that was earned under the issuer's incentive compensation plan based on the achievement of performance goals for a completed performance period. The earned PBRSUs are settled solely in shares of Common Stock.
- Sale of shares with proceeds delivered to the issuer for payment of tax liability incident to the vesting of PBRSUs under the issuer's incentive compensation plan. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 16, 2023.
- Weighted average price, as these shares were sold in multiple transactions at prices ranging from $83.93 to $84.2019, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- Exercise of stock options awarded under the issuer's incentive compensation plan.
- Sale of shares with proceeds delivered to the issuer for payment of tax liability incident to vesting of a restricted stock unit award under the issuer's incentive compensation plan. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 16, 2023.
- Weighted average price, as these shares were sold in multiple transactions at prices ranging from $84.35 to $84.5203, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding.
- Weighted average price, as these shares were sold in multiple transactions at prices ranging from $83.70 to $84.53, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- Option became exercisable in one-third increments beginning on the first anniversary of the September 13, 2018 grant date.
Billionaire Hedge Funds
